Symptomatic osteonecrosis of the hip and knee in patients with systemic lupus erythematosus: Prevalence, pattern, and comparison of natural course
- PMID: 34259056
- DOI: 10.1177/09612033211031007
Symptomatic osteonecrosis of the hip and knee in patients with systemic lupus erythematosus: Prevalence, pattern, and comparison of natural course
Abstract
Objective: Osteonecrosis (ON), also known as avascular necrosis, is characterized by the collapse of the architectural bone structure secondary to the death of the bone marrow and trabecular bone. Osteonecrosis may accompany many conditions, especially rheumatic diseases. Among rheumatic diseases, osteonecrosis is most commonly associated with systemic lupus erythematosus (SLE). We assessed prevalence and distribution pattern of symptomatic ON in patients with SLE and compare the natural courses of hip and knee ON.
Methods: 912 SLE patients admitted between 1981 and 2012 were reviewed. SLE patients with symptomatic ON were retrospectively identified both from the existing SLE/APS database. The prevalence of symptomatic ON was calculated; with ON, the joint involvement pattern was determined by examining the distribution of the joints involved, and then the data about the hip and knee joints were entered in the Kaplan-Meier analysis. Kaplan-Meier methods were used to calculate 5- and 10-year rates of ON-related hip (the hip group) and knee survival (the knee group).
Results: Symptomatic ON developed in various joints in 97 of 912 patients with SLE, and the overall prevalence of ON was detected as 10.6%. The mean age at the time of SLE and ON diagnoses were 27.9 ± 9.9 (14-53) and 34.2 ± 11.3 (16-62) years, respectively. The mean duration from diagnosis of SLE to the first development of ON was 70.7± 60.2 (range = 0-216) months. The most common site for symptomatic ON was the hips (68%, n=66), followed by the knees (38%, n = 37). According to Kaplan-Meier analysis, hip and knee joint survival rates associated with 5-year ON were 51% and 88%, and 10-year survival rates were 43% and 84%, respectively.
Conclusion: We observed that the prevalence of symptomatic ON in patients with SLE was 10.6%. With the estimated 10-year survival rates of 40% versus 84% for the hip and knee joints, respectively, hip involvement may demonstrate a more aggressive course to end-stage osteoarthritis than the knee involvement.
Keywords: Osteonecrosis; natural course; systemic lupus erythematosus.
Similar articles
-
Osteonecrosis in SLE: prevalence, patterns, outcomes and predictors.Lupus. 2018 Jan;27(1):76-81. doi: 10.1177/0961203317711012. Epub 2017 May 22. Lupus. 2018. PMID: 28530464
-
Age at time of corticosteroid administration is a risk factor for osteonecrosis in pediatric patients with systemic lupus erythematosus: a prospective magnetic resonance imaging study.Arthritis Rheum. 2010 Feb;62(2):609-15. doi: 10.1002/art.27236. Arthritis Rheum. 2010. PMID: 20112393
-
Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus.Lupus. 2017 Jun;26(7):715-722. doi: 10.1177/0961203316676384. Epub 2016 Nov 12. Lupus. 2017. PMID: 27831540
-
Osteonecrosis in patients with SLE.Clin Rev Allergy Immunol. 2003 Aug;25(1):13-24. doi: 10.1385/CRIAI:25:1:13. Clin Rev Allergy Immunol. 2003. PMID: 12794257 Review.
-
Osteonecrosis in systemic lupus erythematosus: Systematic insight from the epidemiology, pathogenesis, diagnosis and management.Autoimmun Rev. 2022 Feb;21(2):102992. doi: 10.1016/j.autrev.2021.102992. Epub 2021 Nov 16. Autoimmun Rev. 2022. PMID: 34793961 Review.
Cited by
-
Risk factors and prediction model for osteonecrosis of the femoral head in female systemic lupus erythematosus.Front Immunol. 2024 Aug 21;15:1381035. doi: 10.3389/fimmu.2024.1381035. eCollection 2024. Front Immunol. 2024. PMID: 39234255 Free PMC article.
-
Long-lasting severe knee pain in a SLE patient after renal transplantation: what is the reason? A case report and literature review.Rheumatol Int. 2022 Feb;42(2):349-358. doi: 10.1007/s00296-021-05018-8. Epub 2021 Oct 19. Rheumatol Int. 2022. PMID: 34665297 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous